Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Rev. cuba. med. trop ; 71(2): e371, mayo.-ago. 2019. graf
Artigo em Inglês | CUMED, LILACS | ID: biblio-1093557

RESUMO

Objective: to describe the haemostatic characteristics of the venom as well as the potency appraisal of the polyvalent antiophidic serum against haemotoxicity from Porthidium lansbergii hutmani experimental envenomation. Methods: Evaluation was performed of the venom's lethality, haemorrhagic activity, effects on coagulation and platelet aggregation, proteolytic activity, and neutralization by the commercial antivenom available in the country. Results: Several components with haemostatic activities were found in Porthidium l. hutmanni venom when a study of fibrinogenolytic, haemorrhagic and proteolytic activities was conducted of a pool of P.l.h venom. Porthidium l. hutmanni venom lacked the coagulant and defibrinating activities that are characteristic of bothropic venoms. Porthidium l. hutmanni venom showed very high haemorrhagic and anticoagulant activities. These findings could be related to the presence of multiple metalloproteases, which was evidenced in this study, and also the possible presence of phospholipases or other anticoagulant activity proteins that were not defined here. They inhibited platelet aggregation, suggesting that the venom had some proteins with marked effects on haemostasis. The commercial antivenom proved to be of little effectiveness in neutralizing the crude venom haemorrhagic activity. Conclusions: These toxins cause many physiopathological alterations in bitten patients, creating a clinical picture characterized by oedema, local and systemic haemorrhages, and even necrosis, comparable to that seen in bothropic envenomation. Porthidium l. hutmanni venom has no in vitro procoagulant activity, typical of bothropic venoms, suggesting there are variances in its protein conformation. Porthidium l. hutmanni venom is used for horse immunization. However, in order to preserve the patient's life, it is necessary to improve the immunization process to produce antivenom containing high avidity and specificity antibodies against the major toxins present in this venom. Porthidium l. hutmanni venom has demonstrated being a venom with high lethal, haemorrhagic, proteolytic and procoagulant activities, whose description will have enormous utility among clinicians who deal with these accidents in its geographical distribution areas(AU)


Objetivo: Describir las características hemostáticas del veneno y evaluar la potencia del suero polivalente antiofídico contra la hemotoxicidad provocada por el envenenamiento experimental por Porthidium lansbergii hutmanni. Métodos: Se realizó una evaluación de la letalidad, actividad hemorrágica, efectos en la coagulación y agregación plaquetaria, actividad proteolítica y neutralización por el antiveneno disponible comercialmente en el país. Resultados: Se encontraron varios componentes con actividad hemostática en el veneno de Porthidium l. hutmanni al realizarse un estudio de la actividad fibrinogenolítica, hemorrágica y proteolítica de una muestra de veneno de Porthidium l. hutmanni. El veneno de Porthidium l. hutmanni no mostró la actividad coagulante o defibrinante característica de los venenos botrópicos. El veneno de Porthidium l. hutmanni mostró una elevada actividad hemorrágica y anticoagulante. Estos resultados podrían estar relacionados con la presencia de múltiples metaloproteasas, la que quedó demostrado en el estudio, y también a la posible presencia de fosfolipasas u otras proteínas de actividad anticoagulante que no se definen en el mismo. La inhibición de la agregación plaquetaria sugiere que el veneno contiene algunas proteínas con un marcado efecto sobre la hemostasis. El antiveneno comercial mostró poca efectividad en la neutralización de la actividad hemorrágica del veneno crudo. Conclusiones: Estas toxinas provocan muchas alteraciones fisiopatológicas en las víctimas de mordeduras, creando un cuadro clínico caracterizado por edema, hemorragias locales y sistémicas e incluso necrosis comparable con la que ocurre en el envenenamiento botrópico. El veneno de Porthidium l. hutmanni no tiene la actividad procoagulante in vitro típica de los venenos botrópicos, lo que apunta a variaciones en su conformación proteica. El veneno de Porthidium l. hutmanni de utiliza en la inmunización de los caballos. Sin embargo, para preservar la vida del paciente, es necesario mejorar el proceso de inmunización con vistas a producir un antiveneno que contenga anticuerpos de elevada avidez y especificidad contra las principales toxinas presentes en el veneno. El veneno de Porthidium l. hutmanni ha mostrado ser un veneno de elevada actividad letal, hemorrágica, proteolítica y procoagulante, cuya descripción tendrá una enorme utilidad para los médicos que atienden esos accidentes en sus áreas de distribución geográfica(AU)


Assuntos
Humanos , Masculino , Feminino , Transtornos Hemostáticos/complicações , Venenos de Crotalídeos/efeitos adversos , Anticoagulantes/uso terapêutico
2.
Assiut Medical Journal. 2013; 37 (2): 177-186
em Inglês | IMEMR | ID: emr-170209

RESUMO

Hydroxyelhyl starch [HES] solutions are effective plasma volume expanders. Impairment of coagulation and renal junction occur with large HES volumes infused perioperatively. Therefore, a lower substituted novel HES [Voluven] was developed to minimize hemostatic interactions. The aim of the study is to evaluate the benefit of voluven to reduce hemostatic interactions and preserve renal junction while preserving its efficacy in restoring plasma volume in comparison to HAES-steril [pentastarch]. After approval of our local institutional university ethical committee, and a written consent was obtained from each one. Fifty consecutive adult patients, ASA I and II, scheduled for elective major orthopedic surgery at Assiut University Hospital were included in the study. The patients were allocated into two equal groups [each of 25 patients] according to the type of the study solution used as plasma volume replacement. Group-A: received [Voluven]. Group-B: received HAES-steril. Hemodynamic parameters: central venous pressure [CVP], mean arterial blood pressure [MABP], and heart rate [HR] were recorded before anesthesia induction [baseline], one hour after induction of anesthesia, at the end of surgery, 5 h after surgery and 24 h after surgery. Coagulation profile: Screening tests: prothrombin time [PT], prothrombin concentration [PC], International Normalized Ratio [INR]], partial thromboplastin time [aPTT] and serum fibrinogen level. Specific tests of haemostasis: factor VIII concentration and von Willebrand factor [vWF], Renal function tests: blood urea nitrogen and serum creatinine. Measurements time: sample were collected one day before surgery ['baseline], at 5 h and 24h after surgery. Amount of given colloids [ml], blood loss [ml] and packed RBCs [ml,] were recorded in all patients in two groups. All patients in the two groups were subjected to the some anesthetic management. Data was statistically analyzed using SPSS program version 16, a p value < 0.05 was considered statistically significant. There were significant differences with time as regard PT, PC, and INR in both groups and there was significant difference between the two groups, more increase in PT, INR and more decrease in PC in Haesteril group than in Voluven group. Voluven produced less inhibitory effect on coagulation factor VIII and Von Willibrand factor concentration and consequently, aPTT in comparison with HA ES-steril. Blood loss and transfusion requirements were less with Voluven group than with HAES-steril group. BUN and serum creatinine significantly changed over time in both groups but still within normal range in Voluven groups, but in Haesteril group there were significantly changed over time, mildly elevated above normal range and there was significant difference between the two groups with more increase in Haestril group. Compared with HAES-steril, Voluven are more likely to produce less coagulation abnormalities and less renal impairment in patients undergoing major orthopedic surgery manifested by less blood loss and less erythrocytes transfusion


Assuntos
Humanos , Transtornos Hemostáticos/complicações , Volume Plasmático/fisiologia , Testes de Função Renal , Estudo Comparativo , Hospitais Universitários
4.
Cochabamba; s.n; dic. 2011. 173 p. tab, graf.
Tese em Espanhol | LIBOCS, LILACS, LIBOE | ID: biblio-1296154

RESUMO

La insuficiencia renal crónica es la disminución progresiva de la tasa de filtrado glomerular secundario a pérdida irreversible de nefronas funcionantes, y como alternativa de tratamiento se tiene la hemodiálisis.La presente investigación es cuantitativa y cualitativa, de tipo descriptivo, transversal y retroprospectivo; demuestra el manejo de los accesos vasculares en hemodiálisis por parte del personal de salud en enfermería y pacientes. Se trabajo con una muestra de 176 pacientes y 17 Licenciadas de enfermería de dos instituciones de salud; Caja Nacional de salud y el Hospital Clínico Viedma en el año 2011.Se utilizó un cuestionario para los pacientes y el personal de salud, donde los resultados reflejaron que existe un déficit de conocimientos en cuanto al manejo de los accesos vasculares por parte del paciente y el personal de enfermería; lo cual se asocia con las complicaciones observadas. Se observó una mayor incidencia de infección causada por el mal uso por parte de los pacientes. Se constató los procedimientos mal realizados en accesos vasculares por el personal de salud en enfermería, con mayor incidencia en la institución de la Caja Nacional de Salud


Assuntos
Assistência ao Paciente/enfermagem , Diálise Renal/enfermagem , Diálise Renal/normas , Transtornos Hemostáticos/complicações , Transtornos Hemostáticos/prevenção & controle , Unidades Hospitalares de Hemodiálise , Unidades Hospitalares de Hemodiálise/organização & administração , Bolívia
5.
Artigo em Inglês | IMSEAR | ID: sea-140042

RESUMO

The aim of this paper is to review the literature and identify orofacial manifestations of hematological diseases, with particular reference to anemias and disorders of hemostasis. A computerized literature search using MEDLINE was conducted for published articles on orofacial manifestations of hematological diseases, with emphasis on anemia. Mesh phrases used in the search were: oral diseases AND anaemia; orofacial diseases AND anaemia; orofacial lesions AND anaemia; orofacial manifestations AND disorders of haemostasis. The Boolean operator "AND" was used to combine and narrow the searches. Anemic disorders associated with orofacial signs and symptoms include iron deficiency anemia, Plummer-Vinson syndrome, megaloblastic anemia, sickle cell anemia, thalassaemia and aplastic anemia. The manifestations include conjunctiva and facial pallor, atrophic glossitis, angular stomatitis, dysphagia, magenta tongue, midfacial overgrowth, osteoclerosis, osteomyelitis and paraesthesia/anesthesia of the mental nerve. Orofacial petechiae, conjunctivae hemorrhage, nose-bleeding, spontaneous and post-traumatic gingival hemorrhage and prolonged post-extraction bleeding are common orofacial manifestations of inherited hemostatic disorders such as von Willebrand's disease and hemophilia. A wide array of anemic and hemostatic disorders encountered in internal medicine has manifestations in the oral cavity and the facial region. Most of these manifestations are non-specific, but should alert the hematologist and the dental surgeon to the possibilities of a concurrent disease of hemopoiesis or hemostasis or a latent one that may subsequently manifest itself.


Assuntos
Anemia/complicações , Anemia/diagnóstico , Fácies , Transtornos Hemostáticos/classificação , Transtornos Hemostáticos/complicações , Transtornos Hemostáticos/diagnóstico , Humanos , Doenças da Boca/classificação , Doenças da Boca/etiologia
7.
Rev. colomb. neumol ; 18(2): 84-87, 2006. ilus
Artigo em Espanhol | LILACS | ID: lil-652791

RESUMO

La poliangeitis microscópica (PM) hace parte de los procesos vasculíticos pulmonares, y aunque es una entidad rara, debe ser considerada en pacientes con cuadros de hemorragia alveolar masiva. En muchas ocasiones solo el análisis histológico permite establecer el diagnóstico preciso y con base en esto la toma de decisiones terapéuticas. Presentamos un caso clínico de PM manejado en el Hospital Universitario de San Ignacio (H.U.S.I.) yque fue confirmado con los estudios imagenológicos, inmunológicos e histopatológicos.


Assuntos
Transtornos Hemostáticos/complicações , Transtornos Hemostáticos/diagnóstico , Transtornos Hemostáticos/imunologia , Transtornos Hemostáticos/patologia , Transtornos Hemostáticos , Colômbia
8.
9.
Bol. Acad. Nac. Med. B.Aires ; 76(2): 581-5, jul.-dic. 1998.
Artigo em Espanhol | LILACS | ID: lil-241304

RESUMO

Existe una relación entre los principales factores de riesgo cardiovasculares y el nivel socioeconómico, lo que repercute en la morbimortalidad CV. Esta relación se observó en los jóvenes como también en los adultos. En una población de trabajadores estudiada, se observó una prevalencia marcada de colesterol elevado, IMC aumentada y tabaquismo. En un estudio realizado sobre la relación de aspectos psicosociales en el trabajo y las enfermedades CV, se notó un significativo riesgo relativo (RR) para el grupo con bajo control en el trabajo y apoyo social, el RR aumentó cuando dichos factores se asociaron. En diferentes estudios citados se analizaron los principales FR y el nivel SE, demostrando también su relación inversa. Por último, es importante tener en cuenta la relación que existe entre los FR cardiovascular con el nivel SE y su repercusión sobre la morbimortalidad CV para implementar acciones preventivas adecuadas.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Doenças Cardiovasculares , Fatores Socioeconômicos , Colesterol/efeitos adversos , Diabetes Mellitus/complicações , Distúrbios Nutricionais , Fatores de Risco , Fumar/efeitos adversos , Transtornos Hemostáticos/complicações , Trabalho/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA